已收盤 10-03 16:00:00 美东时间
-0.140
-4.59%
Shares of MBX Biosciences, Inc. (NASDAQ:MBX) rose sharply in pre-market trading...
09-22 17:46
Tharimmune, Inc. will present new results at three upcoming conferences: October 24-29, 2025, at the ACG Annual Scientific Meeting in Phoenix, AZ; November 7-10, 2025, at the AASLD Annual Conference in Washington, DC; and November 9-12, 2025, at the AAPS PharmSci 360 in San Antonio, TX. The company is focused on developing therapeutic candidates for inflammation, immunology, and oncology, including its lead asset TH104 for respiratory and nervous...
09-04 12:01
Shares of Autodesk, Inc. (NASDAQ:ADSK) rose sharply in pre-market trading poste...
08-29 18:58
PRELIMINARY PROSPECTUSSubject to completion, dated August 26, 2025 2,463,601 Shares of Common Stock Pursuant to a registered direct offering and concurrent private placement which closed on July 28, 2025
08-27 23:00
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001861657/000164117225025476/form8-k.htm
08-26 21:37
Shares of Tharimmune are surging Thursday afternoon. The company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104.
08-22 03:28
Shares of Tharimmune, Inc. ($THAR) jumped 207% on Wednesday as the biotechnolog...
08-21 15:45
Tharimmune soared over 42% after hours Wednesday after reporting strong data for its opioid overdose prevention drug.
08-21 14:20
Tharimmune (NASDAQ:THAR) reported quarterly losses of $(0.64) per share. This is a 73.55 percent increase over losses of $(2.42) per share from the same period last year.
08-14 21:52
Tharimmune shares are trading higher after the company announced recent TH-104 ...
08-13 22:37